First Time Loading...
P

Purple Biotech Ltd
TASE:PPBT

Watchlist Manager
Purple Biotech Ltd
TASE:PPBT
Watchlist
Price: 20 ILS -10.31% Market Closed
Updated: May 5, 2024

Purple Biotech Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Purple Biotech Ltd
Revenue Peer Comparison

Comparables:
T
TEVA
TARO
I
INCR
MDWD
R
REKA

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
P
Purple Biotech Ltd
TASE:PPBT
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Revenue
$15.8B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Revenue
$610.8m
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
I
InterCure Ltd
TASE:INCR
Revenue
₪414.8m
CAGR 3-Years
164%
CAGR 5-Years
N/A
CAGR 10-Years
48%
Mediwound Ltd
NASDAQ:MDWD
Revenue
$18.7m
CAGR 3-Years
-5%
CAGR 5-Years
41%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Revenue
₪315.3m
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
1%

See Also

What is Purple Biotech Ltd's Revenue?
Revenue
0 USD

Based on the financial report for Dec 31, 2022, Purple Biotech Ltd's Revenue amounts to 0 USD.